Search
Menu
Home
Sources
About
Contacts
Bioinvent
BioInvent
International
is a
Swedish
research
,
pharmaceutical
and
life science
company
with
focus
on
clinical development
of antibody
drugs
for
immunotherapy
against
cancer
. The company was
founded
in 1983 by and is listed on the
Stockholm Stock Exchange
since
2001
. The company's partners include
Bayer HealthCare
,
Daiichi Sankyo
,
Mitsubishi
Tanabe
and
Servier
.
Martin
Welschof has been
CEO
since
2018
.